Fund moves
4.5%Stake
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 13, 2026 · Filed Nov 16, 2026
A Fennec Pharmaceuticals director sold $240K of Fennec Pharmaceuticals shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$240,000
Shares × reported transaction price
Closed at $11.62 on Nov 13, 2026, 101% above its 52-week low and 9% below its high, after a 14% rise over the previous 30 trading days
52-week range $5.77 (Mar 30, 2026) to $12.78 (Aug 11, 2026), 83% of the way up, from 251 adjusted closes. 30 trading days earlier: $10.20 on Oct 2, 2026. Describes the past only, not a forecast
RSI 61, 24% above its 200-day average, 9% above its 50-day average, 9% below the 52-week high, 20-day volatility 70% a year, against the S&P 500: +15 points over 1 month, +1 points over 3 months, +17 points over 6 months
From the adjusted closes up to Nov 13, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Insider filing
Traded Nov 13 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.